Eptifibatide_Other_Varieties

Name：Eptifibatide

Indication：Acute coromary syndrome, percutaneous coronary intervention

CAS No.:396091-73-9

Molecular formula:C35H49N11O9S2

Eptifibatide (Integrilin, Millennium Pharmaceuticals, also co-promoted by Schering-Plough/Essex), is an antiplatelet drug of the glycoprotein IIb/IIIa inhibitor class.[1] Eptifibatide is a cyclic heptapeptide derived from a disintegrin protein (P22827) found in the venom of the southeastern pygmy rattlesnake (Sistrurus miliarius barbouri). It belongs to the class of the arginin-glycin-aspartat-mimetics and reversibly binds to platelets. Eptifibatide has a short half-life. The drug is the third inhibitor of GPIIb/IIIa that has found broad acceptance

we are peptides manufacturer of varieties peptides from china.

https://www.tcspeptides.com/html/product/2020-12-30/50.html